Skip to main content
Premium Trial:

Request an Annual Quote

Cynvenio Biosystems ClearID Lung Cancer Test

Cynvenio Biosystems has launched its ClearID Lung Cancer blood test. The 11-gene panel leverages next-generation sequencing technology to identify tumor-related genetic mutations that can be treated with targeted therapies. It identifies ctDNA burden and detects somatic mutations as low as .13 percent with an accuracy of 99.76 percent and a sensitivity of 95.9 percent, the firm said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.